Catalent

The non-covalent interaction map explained the regioselectivity of the reaction.

华鲁恒升化工股份有限公司(德州)。2024年营收约350亿。煤化工龙头: 尿素、DMF、醋酸、乙二醇。煤气化平台: 多联产柔性工艺。尼龙6中间体: 己内酰胺。新能源材料: DMC电解液溶剂。

林原化学工業株式会社(兵庫)。2024年売上約1000億円。特殊デンプン、糖類(マルチトール、パラチノース)。機能性糖質: トレハロース世界シェア1位。発酵化学品。食品添加物。

Sika AG (Baar, Schweiz). 2024 Umsatz ~CHF11.2Mrd. Bauchemie: Betonzusatzmittel, Dichtstoffe, Abdichtungssysteme, Klebstoffe. SikaFlex. 27.000 Mitarbeiter. Akquiriert MBCC Group (2023). #1 Bau-Spezialchemie weltweit.

GE Healthcare Life Sciences (now Cytiva). Chromatography resins, cell culture media, filtration. Contrast agents (Omnipaque, Visipaque). Protein A chromatography. Bioprocess manufacturing.

百利科技股份有限公司(岳阳)。2024年营收约40亿。石油化工催化剂: 催化裂化(FCC)催化剂、加氢催化剂。S-Zorb脱硫催化剂。炼油催化剂国产化。中石化核心供应商。

Allosteric enzyme regulation was rewired to eliminate feedback inhibition.

The cell-free system produced 1.7 g/L of active protein in 6 hours.

Adaptive laboratory evolution improved solvent tolerance of our production host.

Navin Fluorine International CRAMS Division (Surat, India). Fluorochemicals CRAMS for global pharma. HFCs (R-134a, R-125), HFOs. Fine chemicals & fluoro-intermediates. Contract research and manufacturing.

中触媒新材料股份有限公司(大连)。2024年营收约5亿。环保催化剂: 柴油SCR催化剂、VOCs催化氧化。分子筛: ZSM-5, TS-1, SAPO-34。钛硅分子筛(丙烯环氧化)。特种催化材料。

The enzymatic cascade converted glucose to the target molecule in 4 steps.

中国宝武钢铁集团(上海)化学事业部。煤化学: 煤焦油深加工、粗苯加工。苯、甲苯、二甲苯、萘、苯酚、苯酐。钢铁化工联产。焦化副产品综合利用。国内最大煤焦油加工企业。

ALTANA ECKART Division (Hartenstein, Deutschland). Metallic effect pigments: aluminum flakes (STAPA), bronze, copper pigments. Pearlescent pigments. Metallic inks, coatings, plastics.

Solubility parameters guided the selection of the optimal polymer for amorphous dispersion.

Livent Corporation (Philadelphia, PA, now part of Arcadium Lithium). Lithium hydroxide, butyllithium, lithium metal. Battery-grade LiOH. LipoLite, LioVedx. Hydroxide process from β-spodumene.

昭和電工株式会社(東京)電子ガス事業。半導体用高純度ガス: アルシン、ジボラン、シラン、三フッ化窒素(NF3)。世界シェアのNF3。合成石英(ADVANTAQ)。ガリウム(LED原料)。化学品総合メーカー。

Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.